Stock Analysis

Results: Becle, S.A.B. de C.V. Exceeded Expectations And The Consensus Has Updated Its Estimates

BMV:CUERVO *
Source: Shutterstock

It's been a good week for Becle, S.A.B. de C.V. (BMV:CUERVO) shareholders, because the company has just released its latest quarterly results, and the shares gained 9.3% to Mex$34.97. Results look mixed - while revenue fell marginally short of analyst estimates at Mex$9.0b, statutory earnings beat expectations 6.9%, with Becle. de reporting profits of Mex$0.28 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

View our latest analysis for Becle. de

earnings-and-revenue-growth
BMV:CUERVO * Earnings and Revenue Growth April 28th 2024

Taking into account the latest results, the current consensus from Becle. de's nine analysts is for revenues of Mex$48.4b in 2024. This would reflect a decent 11% increase on its revenue over the past 12 months. Per-share earnings are expected to accumulate 9.2% to Mex$1.37. Before this earnings report, the analysts had been forecasting revenues of Mex$47.6b and earnings per share (EPS) of Mex$1.36 in 2024. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

There were no changes to revenue or earnings estimates or the price target of Mex$41.32, suggesting that the company has met expectations in its recent result. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Becle. de analyst has a price target of Mex$48.00 per share, while the most pessimistic values it at Mex$33.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Becle. de's rate of growth is expected to accelerate meaningfully, with the forecast 15% annualised revenue growth to the end of 2024 noticeably faster than its historical growth of 10% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.8% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Becle. de to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Becle. de. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Becle. de going out to 2026, and you can see them free on our platform here..

You should always think about risks though. Case in point, we've spotted 1 warning sign for Becle. de you should be aware of.

Valuation is complex, but we're helping make it simple.

Find out whether Becle. de is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.